foxo4-dri senolytic peptide human trial 2024 2025

foxo4-dri senolytic peptide human trial 2024 2025 Targeting Cellular Senescence in Aging and Age-Related Diseases: Challenges, Considerations, and the Emerging Role of and Senomorphic Therapies Peptide Inhibitors Targeting FOXO4-p53 Interactions

Name: foxo4-dri senolytic peptide human trial 2024 2025 Targeting Cellular Senescence in Aging and Age-Related Diseases: Challenges, Considerations, and the Emerging Role of and Senomorphic Therapies Peptide Inhibitors Targeting FOXO4-p53 Interactions
Brand: www.asociacionchamorro.org
SKU: 84113898405
Price: 26.54 USD
Availability: InStock
Rating: 4.2745 (5 reviews)

Peptide Inhibitors Targeting FOXO4 p53 Interactions and Inducing Senescent Cancer Cell specific Apoptosis Journal of Medicinal Chemistry The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells ScienceDirect Senotherapy for chronic lung disease ScienceDirect

SKU: 84113898405 · From www.asociacionchamorro.org

4.3

USD26.54 USD48.54

Pay in 4 interest-free payments of $6.63 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 11 - Aug 16

Description

A few can create genuine safety concerns

In total, we profiled 50 analytes in serum and plasma

From the moment you connect with us, Annie and our medical team guide you through every step, starting with a thorough doctor consultation to ensure safety and effectiveness